Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123984652 | 12398465 | 2 | F | 20160618 | 20160524 | 20160701 | EXP | AU-HQ SPECIALTY-AU-2016INT000290 | INTERCHEM | CHIEW A, RAOS MP, ISBISTER GK. SUM-MAMMARY INJECTION OF ROPIVACAINE RESULTING IN SEVERE TOXICITY WITH SEIZURES. EMERG MED AUSTRALAS. 2016;28(2):246-247 | 23.00 | YR | F | Y | 52.00000 | KG | 20160701 | MD | AU | AU |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123984652 | 12398465 | 1 | PS | DEXMEDETOMIDINE HYDROCHLORIDE. | DEXMEDETOMIDINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | UNK | U | 206628 | |||||||||
123984652 | 12398465 | 2 | SS | MIDAZOLAM | MIDAZOLAMMIDAZOLAM HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | UNK | U | 0 | |||||||||
123984652 | 12398465 | 3 | SS | MIDAZOLAM | MIDAZOLAMMIDAZOLAM HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 5 MG, UNK | U | 0 | 5 | MG | |||||||
123984652 | 12398465 | 4 | SS | PROPOFOL. | PROPOFOL | 1 | Intravenous (not otherwise specified) | UNK | U | 0 | |||||||||
123984652 | 12398465 | 5 | SS | FENTANYL CITRATE. | FENTANYL CITRATE | 1 | Intravenous (not otherwise specified) | UNK | U | 0 | |||||||||
123984652 | 12398465 | 6 | SS | ROPIVACAINE HYDROCHLORIDE. | ROPIVACAINE HYDROCHLORIDE | 1 | 20 ML OF 1 % (200 MG, 3.85 MG/KG) | U | 0 | 3.85 | MG/KG | ||||||||
123984652 | 12398465 | 7 | SS | NORMAL SALINE | SODIUM CHLORIDE | 1 | 200 ML, UNK | U | 0 | 200 | ML | ||||||||
123984652 | 12398465 | 8 | SS | EPINEPHRINE. | EPINEPHRINE | 1 | 1 MG, UNK | U | 0 | 1 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
123984652 | 12398465 | 1 | Sedation |
123984652 | 12398465 | 2 | Sedation |
123984652 | 12398465 | 3 | Seizure |
123984652 | 12398465 | 4 | Sedation |
123984652 | 12398465 | 5 | Sedation |
123984652 | 12398465 | 6 | Local anaesthesia |
123984652 | 12398465 | 7 | Product used for unknown indication |
123984652 | 12398465 | 8 | Local anaesthesia |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
123984652 | 12398465 | LT |
123984652 | 12398465 | HO |
123984652 | 12398465 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
123984652 | 12398465 | Generalised tonic-clonic seizure | |
123984652 | 12398465 | Loss of consciousness | |
123984652 | 12398465 | Maternal exposure during pregnancy | |
123984652 | 12398465 | Partial seizures |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |